Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Trenk

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Cardiology|January 1, 1990
Enoximone versus dopamine in patients being weaned from cardiopulmonary bypassD E Birnbaum, J G Preuner, R Gieseke, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Personalizing antiplatelet therapy with clopidogrelD Trenk, O Zolk, M F Fromm, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazemO E Della Paschoa, V Luckow, D Trenk, et al.
Journal of Clinical Pharmacology|March 1, 1990
Lack of effect of enoximone on the pharmacokinetics of digoxin in patients with congestive heart failureD Trenk, F Hertrich, B Winkelmann, et al.
British Journal of Clinical Pharmacology|November 1, 1982
Absorption of mexiletine after treatment with gastric antacidsP Herzog, K H Holtermüller, W Kasper, et al.
Chest|May 1, 1994
Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary diseaseB R Winkelmann, T H Kullmer, D G Kneissl, et al.
Pharmacopsychiatry|May 1, 1985
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse preventionW Kissling, H J Möller, K Walter, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2014
Clinical implications of drug-drug interactions with P2Y12 receptor inhibitorsJ M Siller-Matula, D Trenk, S Krähenbühl, et al.
The American Journal of Cardiology|May 1, 1996
Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimineE Stengele, G Ruf, E Jähnchen, et al.
Journal of Clinical Pharmacology|April 1, 1993
Effect of concomitantly administered cimetidine or ranitidine on the pharmacokinetics of the 5-HT2-receptor antagonist ritanserinD Trenk, K U Seiler, M Buschmann, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Cardiology|January 1, 1990
Enoximone versus dopamine in patients being weaned from cardiopulmonary bypassD E Birnbaum, J G Preuner, R Gieseke, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Personalizing antiplatelet therapy with clopidogrelD Trenk, O Zolk, M F Fromm, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazemO E Della Paschoa, V Luckow, D Trenk, et al.
Journal of Clinical Pharmacology|March 1, 1990
Lack of effect of enoximone on the pharmacokinetics of digoxin in patients with congestive heart failureD Trenk, F Hertrich, B Winkelmann, et al.
British Journal of Clinical Pharmacology|November 1, 1982
Absorption of mexiletine after treatment with gastric antacidsP Herzog, K H Holtermüller, W Kasper, et al.
Chest|May 1, 1994
Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary diseaseB R Winkelmann, T H Kullmer, D G Kneissl, et al.
Pharmacopsychiatry|May 1, 1985
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse preventionW Kissling, H J Möller, K Walter, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2014
Clinical implications of drug-drug interactions with P2Y12 receptor inhibitorsJ M Siller-Matula, D Trenk, S Krähenbühl, et al.
The American Journal of Cardiology|May 1, 1996
Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimineE Stengele, G Ruf, E Jähnchen, et al.
Journal of Clinical Pharmacology|April 1, 1993
Effect of concomitantly administered cimetidine or ranitidine on the pharmacokinetics of the 5-HT2-receptor antagonist ritanserinD Trenk, K U Seiler, M Buschmann, et al.
Pageof 7